Commerzbank Aktiengesellschaft FI Takes Position in CME Group Inc. $CME

Commerzbank Aktiengesellschaft FI acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 57,708 shares of the financial services provider’s stock, valued at approximately $12,744,000.

A number of other hedge funds have also bought and sold shares of the business. Asset Dedication LLC boosted its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the last quarter. Whipplewood Advisors LLC lifted its position in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership purchased a new stake in CME Group in the fourth quarter worth approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in CME Group in the 4th quarter worth approximately $28,000. Finally, Legacy Wealth Managment LLC ID raised its stake in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.7%

Shares of CME Group stock opened at $267.88 on Tuesday. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $96.32 billion, a P/E ratio of 22.72, a P/E/G ratio of 3.14 and a beta of 0.23. The company has a fifty day moving average of $250.51 and a 200 day moving average of $280.07.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the firm earned $2.96 earnings per share. The business’s quarterly revenue was up .8% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is currently 44.11%.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on CME shares. Piper Sandler dropped their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. Wall Street Zen cut CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. Weiss Ratings lowered shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Morgan Stanley raised their price objective on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Finally, Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Ten analysts have rated the stock with a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $291.81.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.